IL6 and Alzheimer disease: In the study in question, no significant differences were observed in IL-6 levels between the MCI and control groups, which also corroborates the data by Bermejo et al.36, where significantly elevated levels of IL-6 were found only in the plasma of patients with AD, while similar values were observed for the MCI group and healthy controls.